Choroidal neovascularization (CNV) is one of the most important vision-threatening complications secondary to pathological myopia (PM). In the last 20 years, there have been rapid advances in the ...
“By targeting Nogo-A with our antibody, we are able to return healthy growth of the vascular tissue, and stop the abnormal neovascularization that is characteristic of DR,” explained Viann ...
Chugai seeks additional indication approval from Japan MHLW for Vabysmo to treat angioid streaks associated with neovascularization: Tokyo Monday, September 9, 2024, 12:00 Hrs [IS ...
1), exhibited a significant reduction in inflammation, and showed evidence of neovascularization and mucosal regeneration in their ulcerative lesions 3. Adrenomedullin did not cause any adverse ...
Examples of these include radioligand therapy (delivers radioactive emitters directly to tumour-associated targets), DNA repair inhibitors (PARP inhibitors), and antibodies that inhibit tumour ...
Foscenvivint is under clinical development by Eisai and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase I drugs for Colorectal Cancer have a 75% phase transition success ...
Foscenvivint is under development for the treatment of HCV or HBV or NASH-induced decompensated cirrhosis, leukemia such as acute myeloid leukemia (AML), neuroendocrine tumors, ch ...